• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Venture

Capricorn launches €120m Health-tech Fund

  • Mareen Goebel
  • 01 November 2009
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Capricorn Venture Partners has launched a new vehicle designed to invest in early- to mid-stage health technology investments. The fund is seeking to raise €100-120m and will hold a €30m first close at the turn of the year, with a final close expected at the end of 2010. It is Capricorn Venture Partners' fourth fund, and its second sector-specific vehicle working in parallel to its €112m Cleantech Fund raised in 2008. Capricorn has no immediate plans to raise a fund in other sectors.

Investors
For the first close, the fund will seek investments from LPs in the Benelux region. Subsequently, it will seek investors globally and will consider using a placement agent. Investors will include institutionals, family offices and private individuals who may choose to invest via a feeder fund set up by Capricorn.

Investments
Capricorn Health-tech Fund will specifically target technology businesses working on the prevention, diagnosis and treatment of diseases. The human health-tech sector comprises a diverse range of products and services in the following sub-sectors: biopharmaceutical drugs; medical technology; diagnostics; and food ingredients. The fund will seek to make 12-15 lead or co-lead investments during its lifespan with an average of €7-10m allocated per transaction. The fund will begin investing after its first close on a pan-European scale, allocating up to 20% for deals outside the EU.

People
The fund will be managed by Dr Jos Peeters, Dr Frank Bulens, Dr Els Hubloux and Dr Els Vanheusden.

Name
Capricorn Health-tech Fund
Target
€100-120m
Launched
October 2009
Focus
Healthcare sector
Contact
Jos B Peeters
Address
Capricorn Venture Partners NV
De Jonge St. Jacob
Lei 19/1 - B-3000 Leuven
Belgium
Tel. +32 16 28 41 00
Fax +32 16 28 41 08

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Venture
  • UK / Ireland
  • DACH
  • Nordics
  • France
  • Southern Europe
  • CEE
  • Benelux
  • seed
  • Start-up

More on Venture

Redalpine expands leadership team amid CHF 1bn-plus fundraise
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities

Partner Gareth Jefferies discusses early-stage deployment plans and advantages of supporting startups throughout their lifecycle

  • Venture
  • 14 August 2023
Medicxi raises USD 400m to invest in single-focus life sciences companies
Medicxi raises USD 400m to invest in single-focus life sciences companies

GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma

  • Venture
  • 27 July 2023
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline

UK-based impact investorт€™s female leaders discuss deployment plans and the advantages of its syndicate co-investment strategy

  • Venture
  • 21 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013